Search

Your search keyword '"Isernia, G."' showing total 164 results

Search Constraints

Start Over You searched for: Author "Isernia, G." Remove constraint Author: "Isernia, G."
164 results on '"Isernia, G."'

Search Results

1. Urgent endovascular repair of juxtarenal/pararenal aneurysm by off-the-shelf multibranched endograft

3. RANDOMisation Screening for Drug coated or Drug Eluting Device Randomised Trials Among Patients Undergoing Endovascular FemorOPopliteal Procedures (RANDOM-STOP study)

5. Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation

11. RANDOMisation Screening for Drug coated or Drug Eluting Device Randomised Trials Among Patients Undergoing Endovascular FemorOPopliteal Procedures (RANDOM-STOP study)

12. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

13. Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials

15. Acquiring competencies in cerebral ultrasonography: a pragmatic study

16. Impact of frailty on traumatic brain injury outcome. Data from CENTER‑TBI

17. Intracranial pressure management in acute brain‑injured patients: baseline characteristics of the Synapse‑ICU Centers ESICM LIVES 2020

18. Practice of ICP monitoring in acute brain‑injured patients: results from the Synapse‑ICU study

19. One-year experience of a regional service model of teleconsultation for planning and treatment of complex thoracoabdominal aortic disease

31. HERMES: A new stand-alone platform for active noise control and damage detection

32. How to perform endovascular carotid revascularization

34. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells

35. Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits

36. Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells

37. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors

38. The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors

42. Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells

44. Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits

45. Results of the 'endovascular treatment first' policy for infrapopliteal disease

48. Plaque debulking for femoro-popliteal occlusions: Techniques and results

50. Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation

Catalog

Books, media, physical & digital resources